Researcher
Karim Vermaelen
- Keywords:immunology, Immuno-oncology, oncology, respiratory medicine
- Disciplines:Immunology not elsewhere classified, Cancer therapy, Cancer biology, Applied immunology, Immunomodulation therapy, Respiratory medicine, Cell therapy, Vaccinology, Oncology not elsewhere classified, Medical transcriptomics
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Jan 1998 → 30 Sep 2018
Projects
1 - 10 of 32
- REACTION: A modular mRNA-encoded artificial receptor for focused re-ignition of anti-cancer immune responsesFrom1 Oct 2023 → TodayFunding: BOF - projects
- TARgeted Mrna re-engineering for enhanced Antibody and Cellular immunity (TARMAC)From15 Apr 2023 → 14 Apr 2024Funding: IOF - technology concept exploration
- HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVELFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Re-engineering vesicle sorting signals of the mannose-6-phosphate receptor in an mRNA-vaccine approach to enable full anti-cancer T-cell engagementFrom1 Nov 2022 → 31 Oct 2023Funding: Nonprofit institution or equivalents
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Dendritic Cell Immunotherapy In Lung CancerFrom1 Nov 2021 → 31 Oct 2022Funding: Nonprofit institution or equivalents
- SparXells: Enabling next-generation Dendritic Cell Therapy in Lung Cancer and beyondFrom1 Aug 2021 → 31 Jul 2023Funding: IWT / VLAIO personal funding - innovation mandates
- BioGelator for local immunotherapyFrom15 Jul 2021 → TodayFunding: IOF - technology validation in lab
- Proteomics-derived epitopes for dramatically improved anticancer and antibacterial vaccine developmentFrom1 Jan 2021 → TodayFunding: BOF - projects
- SparXells™ : Enabling Next-Generation Dendritic Cell Therapy in Lung cancer and BeyondFrom15 Oct 2020 → 31 Dec 2022Funding: IOF - technology validation in real environment
Publications
41 - 50 of 71
- Activating EGFR mutations in patients with non small cell lung cancer: prevalence and predictors in a caucasian series(2012)Volume: 7
Authors: Thomas Malfait, Liesbeth Ferdinande, Kurt Tournoy, D Galdermans, Marleen Praet, Veerle Surmont, Ramses Forsyth, Karim Vermaelen, Jan Van Meerbeeck
Pages: S36 - S36 - SCID-like symptoms in a patient with chronic mucocutaneous candidiasis caused by STAT1 mutation(2012)Volume: 32
Authors: Melissa Dullaers, Victoria Bordon Maria, K De Waele, I Meyts, L Moens, X Bossuyt, Karim Vermaelen, F De Baets, Filomeen Haerynck
Pages: 51 - 51 - Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma(2011)
Authors: Reinhart Speeckaert, Nanja van Geel, Rosalie M Luiten, Mireille Van Gele, Marijn Speeckaert, Jo Lambert, Karim Vermaelen, Esther PM Tjin, Lieve Brochez
Pages: 3697 - 3703 - Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy(2011)
Authors: Reinhart Speeckaert, Karim Vermaelen, Mireille Van Gele, Marijn Speeckaert, Lieve Brochez
Pages: 334 - 344 - First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi(2010)
Authors: Nanja van Geel, Ilse Mollet, Sofie De Schepper, Esther PM Tjin, Karim Vermaelen, Rachael A Clark, Thomas S Kupper, Rosalie M Luiten, Jo Lambert
Pages: 375 - 384 - Trimodality treatment of early stage Malignant Pleural Mesothelioma (MPM): a single institutional experience(2009)Volume: 4
Authors: Elke Vandenbroucke, Marleen Praet, Karim Vermaelen, Veerle Surmont, FREDERIC DE RYCK, Kurt Tournoy, Robert Gosselin, Wilfried De Neve, Frank Vermassen, Jan Van Meerbeeck
Pages: S778 - S778 - Investigational approaches for mesothelioma
Authors: Veerle Surmont, Eric RE Van Thiel, Karim Vermaelen, Jan Van Meerbeeck
- Between a cough and a wheeze: dendritic cells at the nexus of tobacco smoke-induced allergic airway sensitization
Authors: Lander Robays, Tania Maes, Karim Vermaelen
Pages: 206 - 219 - Dendritic cell-based immunotherapy in lung cancer
Authors: Dieter Stevens, Sandra Van Lint, Karim Vermaelen
- Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer
Authors: Karim Vermaelen
Pages: 544 - 554